切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2023, Vol. 12 ›› Issue (03) : 327 -330. doi: 10.3877/cma.j.issn.2095-3232.2023.03.015

所属专题: 经典病例

临床研究

35例肝血管平滑肌脂肪瘤患者诊治及疗效分析
于雁宾1, 党受琴2, 庄云龙1, 许世友1, 孟令展1, 俞鹏1, 高远1, 李虎1, 曹李1, 朱震宇1,()   
  1. 1. 100039 北京,解放军总医院第五医学中心肝病外科
    2. 266121 青岛市第八人民医院病理科
  • 收稿日期:2023-01-18 出版日期:2023-06-10
  • 通信作者: 朱震宇

Diagnosis, treatment and efficacy of 35 patients with hepatic angiomyolipoma

Yanbin Yu1, Shouqin Dang2, Yunlong Zhuang1, Shiyou Xu1, Lingzhan Meng1, Peng Yu1, Yuan Gao1, Hu Li1, Li Cao1, Zhenyu Zhu1,()   

  1. 1. Department of Hepatic Surgery, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
    2. Department of Pathology, Qingdao Eighth People's Hospital, Qingdao 266121, China
  • Received:2023-01-18 Published:2023-06-10
  • Corresponding author: Zhenyu Zhu
引用本文:

于雁宾, 党受琴, 庄云龙, 许世友, 孟令展, 俞鹏, 高远, 李虎, 曹李, 朱震宇. 35例肝血管平滑肌脂肪瘤患者诊治及疗效分析[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 327-330.

Yanbin Yu, Shouqin Dang, Yunlong Zhuang, Shiyou Xu, Lingzhan Meng, Peng Yu, Yuan Gao, Hu Li, Li Cao, Zhenyu Zhu. Diagnosis, treatment and efficacy of 35 patients with hepatic angiomyolipoma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(03): 327-330.

目的

探讨肝血管平滑肌脂肪瘤(HAML)诊治及疗效。

方法

回顾性分析2011年1月至2020年1月在解放军总医院第五医学中心行手术治疗且经病理学检查明确诊断的35例HAML患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男13例,女22例;年龄26~63岁,中位年龄48岁。病灶单发者32例,多发3例;最大直径1.1~15.3 cm,中位直径5.1 cm;位于左肝17例,位于右肝14例,同时位于左、右肝4例。分析35例患者诊治及疗效。

结果

术前明确诊断HAML 5例,仅占14%;诊断为原发性肝癌13例,肝腺瘤4例,炎性假瘤1例,未明确诊断12例。33例患者行手术切除,切缘距病变1 cm以上或多发结节中较为孤立且直径较小者,同期行射频消融治疗。33例患者术后均经病理检查明确诊断HAML,免疫组化法染色HMB45阳性,其中混合型22例,血管型5例,肌样型4例,脂瘤型2例。另外2例术前行穿刺病理检查明确诊断后行超声引导下射频消融治疗。患者均恢复顺利。所有患者预后良好,1例肌样型术后半年复发,行介入栓塞治疗控制良好,随访2年无明显进展;其余患者随访2年以上,均无复发及远处转移。

结论

HAML为较少见的肝脏良性病变,但临床可表现出一定的恶性倾向,其影像学检查通常缺乏特异性,容易误诊,对于临床诊断困难者,病理检查可作为确诊依据。手术治疗预后良好,条件允许者可作为首选。

Objective

To investigate the diagnosis, treatment and efficacy of hepatic angiomyolipoma (HAML).

Methods

Clinical data of 35 patients pathologically diagnosed with HAML undergoing surgical resection in the Fifth Medical Center of Chinese PLA General Hospital from January 2011 to January 2020 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 13 patients were male and 22 female, aged from 26 to 63 years, with a median age of 48 years. 32 patients were diagnosed with single lesion and 3 cases with multiple lesions. The maximum diameter was ranged from 1.1 to 15.3 cm, and the median diameter was 5.1 cm. The lesions were located in the left lobe of 17 cases, in the right lobe of 14 cases, and in bilateral lobes of 4 cases, respectively. The diagnosis, treatment and clinical efficacy of 35 patients were analyzed.

Results

Preoperatively, 5 cases were diagnosed with HAML, accounting for only 14%. 13 patients were diagnosed with primary liver cancer, 4 cases of hepatic adenoma, 1 case of inflammatory pseudotumor, and 12 cases remained undiagnosed. 33 patients underwent surgical resection. Radiofrequency ablation was performed contemporarily in patients with surgical margin of >1 cm or multiple isolated nodules in small diameter. Postoperatively, all 33 patients were pathologically diagnosed with HAML. Positive HMB45 was detected by immunohistochemical staining, including 22 cases of mixed type, 5 cases of vascular type, 4 cases of myomatous type and 2 cases of lipomatous type. The other 2 patients were pathologically diagnosed by preoperative biopsy and subsequently received ultrasound-guided radiofrequency ablation. All patients recovered well. All patients obtained favorable prognosis. 1 case of myomatous type HAML recurred half a year after surgery, which was properly controlled by interventional embolization, and no significant progression was reported during 2-year follow-up. No recurrence or distant metastasis occurred in the remaining patients during postoperative followed-up for more than 2 years.

Conclusions

HAML is a rare benign liver lesion. However, it represents clinical manifestations of malignant tendency. Imaging examination lacks diagnostic specificity for HAML, which is likely to be misdiagnosed. For the undiagnosed cases, pathological examination can be taken as the diagnostic criteria. Surgical resection yields favorable clinical prognosis, which is highly recommended for eligible patients.

图1 一例HAML患者术前CT检查图注:a为动脉期图像,b为门静脉期图像,c为平衡期图像;CT平扫肝右叶见团块状不均匀稍低密度影,边界清晰,大小约12.4 cm×15.7cm,其内密度不均匀,见斑片状致密影,并见脂肪密度影,最低CT值约-88 HU,增强扫描动脉期不均匀强化,病灶内见增粗迂曲血管影(箭头所示),门静脉期及延迟期病灶强化范围增大,周围血管及胆囊受压;HAML为肝血管平滑肌脂肪瘤
图2 一例HAML患者术后病理检查结果注:a、b为术中情况,可见右肝巨大占位,沿肿瘤完整剥离,切开为实性肿物,直径约15 cm,似有包膜,切面灰红,部分区域为黄色,质软,(右半肝)血管平滑肌脂肪瘤,大小20.0 cm×15.5 cm×11.5 cm;c为病理检查结果,镜下可见成熟脂肪组织及上皮样平滑肌组织,考虑脂瘤型,免疫组化结果示CD34(+),HMB45(++),Actin(-),Desmin(-),CD117(-),CD68(灶+),Dog-1(-);HAML为肝血管平滑肌脂肪瘤
[1]
Li T, Wang L, Yu HH, et al. Hepatic angiomyolipoma: a retrospective study of 25 cases[J]. Surg Today, 2008, 38(6):529-535.
[2]
Vargas SO, Perez-Atayde AR. Mesenchymal hamartoma of the liver and DICER1 syndrome[J]. N Engl J Med, 2019, 381(6):586-587.
[3]
Petrolla AA, Xin W. Hepatic angiomyolipoma[J]. Arch Pathol Lab Med, 2008, 132(10):1679-1682.
[4]
Tsui WM, Colombari R, Portmann BC, et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants[J]. Am J Surg Pathol, 1999, 23(1):34-48.
[5]
Nguyen TT, Gorman B, Shields D, et al. Malignant hepatic angiomyolipoma: report of a case and review of literature[J]. Am J Surg Pathol, 2008, 32(5):793-798.
[6]
Dalle I, Sciot R, de Vos R, et al. Malignant angiomyolipoma of the liver: a hitherto unreported variant[J]. Histopathology, 2000, 36(5):443-450.
[7]
Yang CY, Ho MC, Jeng YM, et al. Management of hepatic angiomyolipoma[J]. J Gastrointest Surg, 2007, 11(4):452-457.
[8]
Prasad SR, Wang H, Rosas H, et al. Fat-containing lesions of the liver: radiologic-pathologic correlation[J]. Radiographics, 2005, 25(2):321-331.
[9]
Basaran C, Karcaaltincaba M, Akata D, et al. Fat-containing lesions of the liver: cross-sectional imaging findings with emphasis on MRI[J]. AJR Am J Roentgenol, 2005, 184(4):1103-1110.
[10]
Low SC, Peh WC, Muttarak M, et al. Imaging features of hepatic angiomyolipomas[J]. J Med Imaging Radiat Oncol, 2008, 52(2):118-123.
[11]
Yan F, Zeng M, Zhou K, et al. Hepatic angiomyolipoma: various appearances on two-phase contrast scanning of spiral CT[J]. Eur J Radiol, 2002, 41(1):12-18.
[12]
Nonomura A, Mizukami Y, Takayanagi N, et al. Immunohistochemical study of hepatic angiomyolipoma[J]. Pathol Int, 1996, 46(1):24-32.
[13]
Wang YJ, Wang YC, Chien CC, et al. Diagnosis of hepatic angiomyolipomata using CT: report of three cases and review of the literature[J]. Clin Radiol, 2009, 64(3):329-334.
[14]
Wang SN, Tsai KB, Lee KT. Hepatic angiomyolipoma with trace amounts of fat: a case report and literature review[J]. J Clin Pathol, 2006, 59(11):1196-1199.
[15]
Anysz-Grodzicka A, Pacho R, Grodzicki M, et al. Angiomyolipoma of the liver: analysis of typical features and pitfalls based on own experience and literature[J]. Clin Imaging, 2013, 37(2):320-326.
[16]
Zhou YM, Li B, Xu F, et al. Clinical features of hepatic angiomyolipoma[J]. Hepatobiliary Pancreat Dis Int, 2008, 7(3):284-287.
[17]
王彦冬, 经翔, 丁建民, 等. 肝血管平滑肌脂肪瘤超声造影表现[J/CD]. 中华医学超声杂志(电子版), 2013(1):64-67.
[18]
张源. 钆塞酸二钠增强MRI鉴别乏脂肪型血管平滑肌脂肪瘤和肝细胞癌[J]. 中华医学杂志, 2022, 102(3):208.
[19]
卢艳丽, 刘立恒, 曾蒙苏. 肝脏上皮样血管平滑肌脂肪瘤的临床与MRI特征分析及与肝细胞肝癌的鉴别[J]. 临床放射学杂志, 2021, 40(2):286-290.
[20]
Klompenhouwer AJ, Verver D, Janki S, et al. Management of hepatic angiomyolipoma: a systematic review[J]. Liver Int, 2017, 37(9): 1272-1280.
[1] 李友, 唐林峰, 杜伟伟, 刘海亮, 余新水, 沈佳宇, 巨积辉. 皮瓣联合掌长肌腱折叠单排三点式固定治疗指背侧创面伴锤状指畸形的临床效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 485-490.
[2] 刘敏, 唐恩溢, 刘喆, 葛苏蒙, 刘梅, 孙国文. 计算机导航技术在口腔颌面部微小异物取出手术中的应用[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 375-379.
[3] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[4] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[5] 杨建波, 马欢, 黄小梅, 刘华柱. 结肠镜辅助下EMR、CSP和RFA术治疗直径<1cm结直肠息肉的疗效和安全性比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 76-79.
[6] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[7] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[8] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[9] 臧宇, 姚胜, 朱新勇, 戎世捧, 田智超. 低温等离子射频消融治疗腹壁疝术后补片感染的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 687-692.
[10] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[11] 陈宗杰, 胡添松. 肝外伤破裂患者治疗后胆漏发生影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 836-840.
[12] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[13] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[14] 刘卓, 张宗明, 张翀, 刘立民, 赵月, 齐晖. 腹腔镜手术治疗高龄急性梗阻性化脓性胆管炎患者的安全性与术式选择[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 795-800.
[15] 王妍, 李征, 卓奇峰, 周陈杰, 吉顺荣, 徐晓武, 陈洁, 虞先濬. 微小无功能性胰腺神经内分泌瘤外科治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 607-614.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?